PME Signs A$10M – 7 Year Contract with Munich based Ludwig-Maximilians-Universität (LMU Klinikum)

15 October 2020; Company Announcement - LMU Klinikum Munich - Acrobat pdf 118k Highlights PME signs 7-year, A$10M deal with LMU Klinikum LMU Klinikum is one of the largest university hospitals in Germany Visage technology to be deployed throughout LMU Klinikum’s imaging departments replacing systems from legacy vendors Extends PME’s footprint in the European hospital segment Leading health imaging company Pro Medicus Limited [ASX: PME] today announced its wholly- owned German subsidiary, Visage Imaging GmbH, has signed a 7-year A$10million contract with Munich based Ludwig-Maximilians-Universität (LMU Klinikum) one of the largest university hospitals in Europe. The contract will see the company’s Visage 7 technology implemented across all LMU Klinikum’s radiology and subspecialty imaging departments replacing existing legacy PACS systems with a single centralized instance of the Visage 7 Enterprise Imaging Platform. Visage is also used in the hospital’s state of the art operating theatre suite for HD video documentation and point-of-care Ultrasound archival and viewing. LMU Faculty of Medicine is the largest medical training institution in southern Germany and regarded as one of the top academic hospitals in Europe. The implementation is scheduled to commence in December 2020. “We look forward to taking our partnership with Visage to the next level as we implement their technology across our radiology department,” said Dr Kurt Kruber, CIO of LMU Klinikum. “The Visage platform provides a highly scalable and reliable platform combined with sophisticated clinical features that will support us in both day-to-day patient care and advanced research.” “We are very excited about this project,” said Dr Malte Westerhoff, Managing Director of Visage Imaging GmbH. “LMU Klinikum is a thought leader in making a digital strategy a core principle of their operations. We are confident that our technology and

PME Signs Research Collaboration Agreement with NYU Langone Health

11 September 2020; Company Announcement NYU Research Collaboration Sept 2020 - Acrobat pdf 114k Highlights PME signs multi-year Research Collaboration agreement with NYU Langone Health PME and NYU Langone Health to jointly develop next-generation enterprise imaging solutions PME to establish Research/R&D Hub in New York City New Hub to form the foundation for Visage research activities in the U.S. Significant investment in future PME products Leading health imaging company Pro Medicus Limited [ASX: PME] today announced its wholly- owned U.S. subsidiary, Visage Imaging, Inc., has signed a multi-year Research Collaboration agreement with NYU Langone Health (NYU Langone), one of the most highly regarded health systems in North America. Under the terms of the agreement, the two parties will work together to design and develop next-generation products for enterprise imaging in areas such as workflow optimization, integration with multi-vendor reporting platforms, as well as integration of artificial intelligence (AI) technology. NYU Langone will also become a member of the Visage AI Accelerator program. “This is a major milestone for our company,” said Dr Sam Hupert, Pro Medicus CEO. “We changed the paradigm of what a diagnostic imaging (PACS) product should be by natively integrating 3D and advanced visualisation into a single platform. We believe this, combined with our proprietary streaming platform, has given us an 18 to 24 month technology lead. We are now looking at what is next, what a system would look like in say 3 to 5 years, and are starting to do the research and development to make that a reality and then be the first to commercialise it.” In addition to working on-premise at NYU Langone, PME will establish its own R&D Hub in New York City to spearhead PME’s research and

PME Signs A$25M – 7 Year Contract with NYU Langone Health

11 September 2020; Company Announcement NYU Sept 2020 - Acrobat pdf 118k Highlights PME signs 7-year, A$25M deal with NYU Langone Health NYU Langone ranked in the 10 best hospitals by U.S. News & World Report 2020- 2021 Tier 1 academic institution which includes the renowned NYU Grossman School of Medicine Visage technology to be deployed throughout NYU’s imaging departments replacing systems from legacy vendors Extends PME’s footprint in the tier 1 U.S. academic hospital segment Transaction-based model with potential upside Leading health imaging company Pro Medicus Limited [ASX: PME] today announced its wholly-owned U.S. subsidiary, Visage Imaging, Inc., has signed a 7-year contract with NYU Langone Health (NYU Langone), one of the largest health systems in the state of New York and one of the most respected and innovative healthcare institutions in North America. The contract, based on a transaction-based licensing model, will see the company’s Visage 7 technology implemented across all of NYU Langone’s radiology and subspecialty imaging departments, including breast imaging, replacing all existing legacy PACS with a single centralized instance of the Visage 7 Enterprise Imaging Platform. The implementation will span 6 hospitals and numerous additional locations across the NYU Langone healthcare network. Planning for the rollout is to commence in Q2 FY21, with the first sites scheduled to go-live in Q3 FY21. “NYU Langone completed a thorough selection process that required the final round of vendors to perform extensive on-site pilots. This enabled NYU to assess the differences between systems and, importantly, do so in their production environment, which is the ultimate test of how a product will perform,” said Dr Sam Hupert, Pro Medicus CEO. “Winning this deal further validates our belief that we have a unique and highly differentiated

Pro Medicus signs A$22M – 5-year contract with Northwestern Memorial HealthCare

1 June 2020; Company Announcement - Northwestern - Acrobat pdf 108k Highlights PME signs 5-year, A$22M deal with Northwestern Memorial HealthCare for Visage 7 Extends PME’s footprint in the U.S. academic hospital segment, as well as regionally based community hospitals Transaction-based licencing model Leading health imaging company Pro Medicus Limited [ASX: PME] today announced its wholly- owned U.S. subsidiary, Visage Imaging, Inc., has signed a 5-year contract with Chicago based Northwestern Memorial HealthCare (NMHC). The contract, which is based on a transaction-based licensing model, will see the company’s Visage 7 technology implemented at NMHC commencing in Q1 FY21. Authorised by the Board of Pro Medicus Limited.

Pro Medicus Signs 5-Year Platform Deal with Nines for Future Radiology Services

30 December 2019; Company Announcement - Nines Dec 2019 - Acrobat pdf 283k Highlights Visage 7: the cloud-based platform for Nine’s development of future radiology services Transactional based model with potential upside as volumes grow Opens up potential for new Radiology-as-a-Service market for Visage Adds to PME’s growing footprint in North America Leading health imaging company Pro Medicus Limited [ASX: PME] today announced its wholly-owned U.S. subsidiary, Visage Imaging, Inc., has signed a 5-year, multi-million dollar contract with Palo Alto based Nines. Nines is co-founded by CEO David Stavens PhD, a highly respected Silicon Valley inventor/entrepreneur, and CMO Alexander Kagen, MD the Site Chair of Radiology at Mount Sinai’s West and St. Luke’s Hospitals in New York City. The offering, based on Visage 7 technology, will be hosted in Google Cloud Platform and will provide Nines with an immensely scalable and highly optimised platform. “This is an extremely exciting opportunity for us," said Pro Medicus CEO Dr Sam Hupert. “The team behind Nines are incredibly well known and respected in machine learning, AI, and radiology circles. Partnering with them will allow us to support their efforts to develop future products with our highly optimised Visage 7 cloud-based solution for on-demand reads.” The five-year contract is based on committed exam volumes that step up year-on-year aligning with projected growth of the Nines offering in the market. This will result in base revenue to Pro Medicus in excess of AUD$6M over the life of the contract with the potential for significant upside. Implementation will begin in the next few weeks with go live anticipated in early Q2 of the 2020 calendar year. “Leading healthcare institutions expect high-quality radiology reports 24/7. Visage and Nines are collaborating on a modern

Dr Sam Hupert | CEO on Update

PME OB 4 Nov 2019 Final - Acrobat pdf 410k 4 November 2019 Open Briefing interviewed Pro Medicus CEO, Dr Sam Hupert, where he discussed: New 5-year contract with The Ohio State University Wexler Medical Center Pipeline growth and recent influx of RFPs Competitive landscape - WA Health contract Upcoming RSNA 2019        

Pro Medicus Signs A$9M 5-year Contract with The Ohio State University Wexner Medical Center

4 November 2019; Company Announcement - OSUWMC Final - Acrobat pdf 120k Highlights PME signs 5-year deal with The Ohio State University Wexner Medical Center (OSUWMC) Visage 7 to be implemented across all of OSUWMC’s radiology departments Transaction-based financial model with potential upside Leading health imaging company Pro Medicus Limited [ASX: PME] today announced its wholly-owned U.S. subsidiary, Visage Imaging, Inc., has signed a 5-year contract with The Ohio State University Wexner Medical Center (OSUWMC). OSUWMC is a large multi-disciplinary academic medical center located in Columbus, Ohio. OSUWMC employs approximately 30,000 staff, 1,700 physicians, supporting over 1,500 inpatient beds. It is also the teaching hospital for The Ohio State University College of Medicine (OSUCOM). The contract, based on a transaction-based licensing model, will see Pro Medicus’ Visage 7 technology implemented across all of OSUWMC’s radiology departments spanning seven (7) hospitals and outpatient clinics, as well as integrated to OSUWMC’s electronic health record. The implementation will begin in Q2 FY20, and complete in mid-2020.  

Pro Medicus Signs $27M – 7 year Contract with US-based Partners HealthCare

20 November 2018; Company Announcement - Pro Medicus Signs Partners HealthCare - Acrobat pdf 119k Highlights PME signs 7 year deal with Partners HealthCare in the USAInitial rollout to include Massachusetts General Hospital and Brigham and Women’s Hospital, ranked fourth and twentieth best hospitals in the USA Estimated value to PME for the initial rollout in excess of AUD $27M Scope to expand to the rest of Partners HealthCare in the future Transaction-based model with significant potential upside Two of the top four hospitals in the USA are now Visage clients  Leading health imaging company Pro Medicus Limited [ASX: PME] today announced its wholly-owned US subsidiary, Visage Imaging, Inc., has signed an AUD $27 million, 7-year contract with Partners HealthCare (“Partners”), the largest health system in the state of Massachusetts and one of the largest and most respected health providers in North America.  Partners was founded in 1994 by Massachusetts General Hospital (“MGH”) and Brigham and Women's Hospital (“BWH”). Partners is a national leader in biomedical and data science research, including the MGH & BWH Center for Clinical Data Science.  The contract, based on a transaction licensing model, will see Pro Medicus’ Visage 7 technology implemented at Partners’ two flagship hospitals, MGH and BWH, eliminating their legacy PACS with scope to expand to other Partners network hospitals at a later date.  Dr Sam Hupert, Pro Medicus CEO, described the deal as a ‘milestone’ for Pro Medicus. “Not only is it our biggest deal to date, there is the potential for further upside within the Partners network after this initial rollout is completed. In addition, MGH and BWH are two of the most prestigious medical institutions in North America renowned for their medical research, as well as their key roles as teaching hospitals

Pro Medicus Showcases AI Advances at RSNA 2017

22 November 2017; Company Announcement - Pro Medicus Showcases AI Advances at RSNA 2017 - Acrobat pdf 120k Highlights Visage unveils advances in artificial intelligence (AI) at the RSNA 2017 Machine Learning Showcase. Visage 7 - the only solution to combine both AI research and AI aided diagnostic interpretation capabilities in a single, enterprise imaging platform. Algorithms developed by Visage as well as third parties will be demonstrated. Leading health imaging company Pro Medicus Limited [ASX: PME] today announced that its wholly owned US subsidiary, Visage Imaging, Inc., will debut its artificial intelligence (AI) offerings at the Radiological Society of North America (RSNA) 2017 annual meeting (Visage Kiosk 8149M, North Hall B) as part of the inaugural RSNA Machine Learning Showcase (November 26-30, Chicago, Illinois). Significant promise and investment are driving a wide range of AI initiatives in healthcare IT particularly in the area of health imaging. The company’s vision is to utilise its R&D capability and market leading technology to deliver cutting-edge AI offerings to optimize Enterprise Imaging worldwide. Visage will showcase technology that makes Visage 7 the first and only system to combine both AI research and AI assisted diagnostic interpretation in the same Enterprise Imaging platform. “Historically, imaging platforms for research and diagnostic purposes have been totally separate,” said Malte Westerhoff PhD, Co-founder and Global CTO of Visage Imaging. Dr Westerhoff continued, “Visage’s GPU-based architecture is ideal for AI and, combined with our open APIs, will enable us to unify research and diagnostic imaging in ways not available before. This will enable AI breakthroughs to advance patient care by giving radiologists faster access to new tools that help increase productivity and improve clinical accuracy.” The company will also show algorithms working on the ultrafast

Pro Medicus Signs $18M – 7 Year Contract with Yale New Haven Health

17 November 2017; Company Announcement - Pro Medicus Signs Yale - Acrobat pdf 83k Highlights 7 year deal with Yale New Haven Health in the US. Estimated value to PME in excess of AUD $18M. Visage 7 to be implemented across Yale’s radiology departments and enterprise-wide for clinical access to imaging results. Transaction-based model with potential upside. Consolidates PME in the US academic radiology space. Leading health imaging company Pro Medicus Limited [ASX: PME] today announced its wholly owned US subsidiary, Visage Imaging, Inc., has signed an AUD $18 million, 7 year contract with Yale New Haven Health (“Yale”), affiliated with Yale University and Yale Medicine, the clinical practice of the Yale School of Medicine and the largest academic multi-specialty practice in New England. Yale is one of the leading, most respected academic institutions in the US. The contract, based on a transaction licensing model, will see Pro Medicus’ Visage® 7 technology implemented across all of Yale’s radiology departments and integrated to their EHR for imaging results. The implementation will span five hospitals — Bridgeport, Greenwich, Lawrence+Memorial, Westerly, and Yale New Haven hospitals, including Yale New Haven’s Children Hospital and Smilow Cancer Hospital at Yale New Haven, as well as numerous additional imaging locations across the state of Connecticut. Yale New Haven Hospital is the primary teaching hospital of the Yale School of Medicine. The first locations are scheduled to go live early in the second half of FY2018 with the remainder to be rolled out over a six month period. “This is another very significant contract for us,” said Dr Sam Hupert, Pro Medicus CEO. “Yale is one of the top academic institutions in the US and its’ medical school is renowned. Their decision further validates

PharmacySydney.com MJDHealthPharmacy.com
Go to Top